Fungal agents isolated from cancer patients

Revista Latinoamericana de Microbiologia

Volumn 40, Issue 1-2, 1998, Pages 15-24

  Gasca, María Araceli Álvarez ^a   Licea, Bertha Argüero ^a   Castañeda, Amada Pliego ^a   Tena, Samuel García ^a  

^a NONE

Author keywords

Cancer; Mycoses

Indexed keywords

ARTICLE; ASPERGILLUS; CANCER; CANCER CLASSIFICATION; CANCER STAGING; CANDIDA ALBICANS; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; COMORBIDITY; FUNGUS IDENTIFICATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL INSTRUMENTATION; MYCOSIS;

ASPERGILLOSIS; ASPERGILLUS; CANDIDA; CANDIDIASIS; CATHETERIZATION; EQUIPMENT CONTAMINATION; HUMANS; IMMUNOCOMPROMISED HOST; MYCOSES; NEOPLASMS; OPPORTUNISTIC INFECTIONS; SPECIES SPECIFICITY; SURGICAL WOUND INFECTION;

EID: 0342314493     PISSN: 01874640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. ALLO, M.D.; J. MILLER; & T. TOWNSEND, 1987. Primary cutaneous aspergillosis associated with Hickman intravenous catheters. N. Engl. Med. 317:1005-1108.
2. ANAISSIE, E.; G. P. BODEY; H. KANTARJIAN; E. S. VARTIVARIAN; R. HOPFER.; J. HOY & K. ROLSTON, 1989. New spectrum of fungal infections in patients with cancer. Rev. Infect. Dis. 11:369-376.
3. ANAISSIE, E., 1992. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin . Infec. Dis. 14: 43-53.
4. BODEY, G. P. & E. S. VARTIVARIAN, 1989. Aspergillosis. Eur. J. Clin. Microbiol. Infect. Dis. 8: 413-437.
5. BRANCHINI, M. L.; M. A. PFALLER; R. CHALBERG, T. FREMPONG & H. D. TSEMBERG, 1994. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. J. Clin. Microbiol. 32:452-456.
6. BROSS, J.; G.H. TALBOT; G. MAISLIN; S. HURWITZ & B.L. STROM, 1989. Risk factors for nocosomial candidemia: a case-control study in adults without leukemia. Am. J. Med. 87: 614-620.
7. DE GREGORIO, M. W.; W. M. F. LEE; CH. A. LINKER; R. A. JACOBS; C. A. RIES, 1982. Fungal infections in patients with acute leukemia. Am. J. Med. 73:543-548.
8. DENNING, D.W. & A. D. STEVENS, 1990. Antifungal and surgical treatment of invasive aspergillosis: review of 2, 121 cases. Rev. Infect. Dis. 12: 1147-1201.
9. EPPES, S. C.; J.L. TROUTMAN & L. T. GUTMAN, 1989. Outcome of treatment of candidemia in children whose central catheters were removed or retained. Pediatric. Infec. Dis. J. 8: 99-104.
10. GOODRICH, J. M.; E. C. REED & E. E. MORI, 1991. Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation. J. Infect. Dis. 164: 731-740.
11. GUIOT, H. F. L.; W. E. FIBBE & J. W. WON'T, 1994. Risk factors for fungal infections in patients with malignament hematologic disorders: implications for empirical therapy and prophylaxis Clin. Infect. Dis. 18: 525-532.
12. HARDFIELD, T. L.; B. SMITH; R. E. WINN & C. GUERRA, 1987. Mycoses caused by Candida lusitaniae. Rev. Infect. Dis. 9: 1006-1012.
13. HORN, R.; B. WONG; T. E. KIEHN & D. ARMSTRONG, 1985. Fungemia in a cancer hospital: changing frecuency, earlier onset, and results on therapy. Rev. Infect. Dis. 7: 646-655.
14. IWEN, C. P.; M. D. KELLY; C. E. REED & H.S HINRICHS, 1995. Invasive infections due to Candida krusei in immunocompromised patients not treated with Fluconazole. Clin. Infect. Dis. 20: 342-347.
15. JARVIS, R.W., 1995. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin. Infect. Dis. 20: 1526-1530.
16. KARABINIS, A.; C. HILL; B. LECLERCK; C. TANCREDE; B. BAUME & A. ANDREMONT, 1988. Risk factors for candidemia in cancer patients: a case-control study. J. Clin. Microbiol. 26: 429-232.
17. KARP, J. E.; J. D. DICK; C. ANGELOPULOS; P. CARACHE; L. GREEN; P.L. BURKE & R. SARA, 1986. Empiric use of vancomycin during prolonged treatment induced granulocytopenia Am. J. Med. 81: 237-242.
18. LECCIONES, J. A.; J.W. LEE & E.E. NAVARRO, 1992. Vascular catheter-associated fungemia in patients with cancer: Analysis of 155 episodes. Clin. Infect. Dis. 14: 875-83.
19. MAKSYMIUK, W.A.; S. THONG-PRASERT; R. HOPFER; M. LUNA; V. FAINSTEIN & G.P. BODEY, 1984. Systemic candidiasis in cancer patients. Am. J. Med. 77: 20-27.
20. MERZ, W. G.; J. E. KARP; D. SCHRON & R. SARAL, 1986. Increased incidence fungemia by Candida krusei. J. Clin. Microbiol. 24: 581-584.
21. MERZ, W. G.; W. KHAZAN; M. A. JABRA-RISK; G. J. OSTERHOUT & P.F. LEHMANN, 1992. Strain delineation and epidemiology Candida (Clavispora) lusitaniae. J. Clin. Microbiol. 30: 449-454.
22. MEUNIER, F. & N. AOUN BITAR, 1992. Candidemia in immunocompromised patients. Clin. Infect. Dis. 14: 120-125.
23. MORA, T. A.; B. M. PRESNO & G. A. MENESES, 1990. Infección por hongos en autopsias de pacientes con cáncer. Rev. Inst. Cancerol. (Mex). 199036: 1033-1037.
24. PERFECT, R. J. & W. A. SCHELL, 1996. The new fungal opportunists are coming. Clin. Infect. Dis. 22: 112-118.
25. PFALLER, A. M, 1992. Nocosomial Candidiasis: Emerging species, reservoirs, and modes of transmission. Clin. Infect. Dis. 22: 89-94.
26. RICHET, M.H., A. ANDREMONT; C. TANCREDE; J. L. PICO & R.W. JARVIS, 1991. Risk factors for candidemia in patients with acute lymphocyte leukemia. Rev. Infect. Dis. 13: 211-215.
27. RINALDI, M.G., 1989. Emerging opportunists. Infect. Dis. Clin. North Am. 3: 53-64.
28. SILVA, J.; R. R. LABORDA; G. ALMENDRO & R. SALIM, 1990. Detection of opportunistic yeast pathogens in hospitalized inmunocompromised patients. Rev. Latamer. Microbiol. 261-264.
29. SLAVIN, R. E.; M.A. DIAS & R. SARAL, 1978. Cytosine arabinoside induced gastrointestinal toxic alterations in sequential chemotherapeutic protocols. A clinical-pathologic study of 33 patients. Cancer. 42:1747-1759.
30. SWERDLOFF, N. J.; S.G. FILLER; & E.J. EDWARDS, 1993. Severe candidal infections in neutropenic patients Clin. Infec. Dis. 17 (suppl 2): 5457-5467.
31. UZUN, O. & J.E. ANAISSIE, 1996. Problems and controversies in management of hematogenous candidiasis. Clin. Infect. Dis. 22: 95-101.
32. WALSH, T. J. & W. G. MERZ, 1986. Pathologic features in the human alimentary tract associated with invasiveness of Candida tropicalis. Am. J. Clin. Pathol. 85: 498-502.
33. WEEMS, J. J., 1992. Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. Clin. Infect. Dis. 14: 756-766.
34. WINGARD, J.R., 1995. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin. Infect. Dis. 20: 115-125.